Vivesto
0,23
SEK
-1,08 %
VIVE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
-1,08%
-20,86%
-18,33%
-10,35%
-11,73%
-30,14%
-87%
-95,52%
-98,73%
Vivesto is a research company. The company specializes in the research and development of drugs for serious diseases in oncology. The technology is based on the company's technical platform where research is based on nanotechnology. Today, operations are conducted mainly in the Nordic countries and North America. The company was founded in 1999 and has its headquarters in Uppsala.
Læs mereMarkedsværdi
123,48 mio. SEK
Aktieomsætning
152,11 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
20.2
2025
Årsrapport '24
8.5
2025
Delårsrapport Q1'25
8.5
2025
Generalforsamling '25
ViserAlle indholdstyper
Vivesto strengthens Cantrixil program with new preclinical results and patent application
Vivesto’s Paccal Vet receives Limited Market classification in EU
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools